Late-Stage Conversion of a Metabolically Labile Aryl Methyl Ether-Containing Natural Product to Fluoroalkyl Analogs.

We report the conversion of aryl methyl ethers and phenols into six fluoroalkyl analogs through late-stage functionalization of a natural product-derived FDA-approved therapeutic. This series of sh...